A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing ...

Instead of fixing one of the many genes that can be mutated, the technique addresses a type of mutation they share, a stop ...

This manuscript reports on the application of ribosome profiling (EZRA-seq and eRF1-seq) combined with massively parallel reporter assays to identify and characterize a GA-rich element associated with ...

Introduction: The nonsense-mediated mRNA decay (NMD) process is recognized as the quality control of mRNAs to maintain their integrity and production of functional proteins. Readthrough of aberrant ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will leave the United States unprepared for the ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects dedicated to designing messenger RNA (mRNA) vaccines for pandemic preparedness.

Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday that his department will be terminating close to $500 million in mRNA-vaccine contracts and would not fund mRNA development ...